Non-invasive Low-level Tragus Stimulation in Cardiovascular Diseases.

Share on facebook
Share on twitter
Share on google
Share on linkedin
Share on email
Share on print

Non-invasive Low-level Tragus Stimulation in Cardiovascular Diseases.

Abstract
Low-level tragus stimulation (LLTS) is a non-invasive approach of transcutaneous vagus nerve stimulation. LLTS has applications in diseases of multiple systems, including epilepsy, depression, headache and potentially several cardiovascular diseases. LLTS has shown promising results in suppressing AF, alleviating post-MI ventricular arrhythmias and ischaemia-reperfusion injury along with improving diastolic parameters in heart failure with preserved left ventricular ejection fraction (HFpEF). Preliminary pilot clinical studies in patients with paroxysmal AF, HFpEF, heart failure with reduced ejection fraction and acute MI have demonstrated promising results. The beneficial effects are likely secondary to favourable alteration of the sympathovagal imbalance. On-going exploratory work focused on underlying mechanisms of LLTS in cardiovascular disease states and larger scale clinical trials will shed more light on the non-invasive modulation of the neuro-immune axis.

PMID: 32637119 [PubMed]

Arrhythm Electrophysiol Rev. 2020 Jun 03;9(1):40-46

Authors: Jiang Y, Po SS, Amil F, Dasari TW

Join Our Newsletter


Mike

Mike

Comments?